Reaction

Transfusion Reaction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 864 reports · 12 co-occurring drugs

As of the last recalculation, Transfusion Reaction appears in 864 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is DEFERASIROX (PRR 32.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Deferasirox3432.132.2
Human Immunoglobulin G2226.326.4
Azacitidine2823.523.5
Erythropoietin1922.722.8
Cefazolin821.321.3
Azacitidine For1418.818.8
Eculizumab3918.118.1
Cytarabine3615.015.0
Niraparib1112.112.1
Venetoclax2911.711.7
Temozolomide1011.611.6
Voxelotor44.34.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.